Total planned funding: $1,442,228,987
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $312,258,008 |
| Nigeria | $231,547,303 |
| Zambia | $216,862,675 |
| Mozambique | $127,448,532 |
| Uganda | $105,181,218 |
| South Africa | $70,970,682 |
| Zimbabwe | $70,675,653 |
| Rwanda | $46,891,480 |
| Haiti | $41,016,349 |
| Democratic Republic of the Congo | $37,996,157 |
| Eswatini | $36,598,826 |
| Ethiopia | $27,717,734 |
| Namibia | $22,306,379 |
| Malawi | $16,705,805 |
| Botswana | $14,632,966 |
| Ukraine | $12,487,292 |
| Vietnam | $9,967,820 |
| Côte d'Ivoire | $9,218,526 |
| Lesotho | $6,494,432 |
| Burundi | $5,668,968 |
| Cameroon | $5,527,521 |
| Kenya | $2,541,693 |
| Central America Region | $2,529,008 |
| South Sudan | $2,190,198 |
| Ghana | $2,021,918 |
| Indonesia | $1,300,000 |
| Angola | $1,250,000 |
| Caribbean Region | $1,071,844 |
| Cambodia | $650,000 |
| Burma | $500,000 |
| Central Asia Region | $0 |
| Dominican Republic | $0 |
Organizational Types
| Private Contractor | $1,442,228,987 |
Program Areas
| Treatment | $981,192,090 |
| Care | $185,345,344 |
| Governance and Systems | $102,988,220 |
| Testing | $88,016,028 |
| Prevention | $83,676,346 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $666,564,481 |
| HTXS: Treatment: Adult Treatment | $290,795,210 |
| HVCT: Testing: HIV Testing and Counseling | $88,016,028 |
| HKID: Care: Orphans and Vulnerable Children | $78,691,383 |
| OHSS: Health Systems Strengthening | $72,193,203 |
| HBHC: Care: Adult Care and Support | $56,723,211 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $52,794,291 |
| HVTB: Care: TB/HIV | $33,712,660 |
| PDTX: Treatment: Pediatric Treatment | $23,832,399 |
| HVSI: Strategic Information | $16,532,927 |
| PDCS: Care: Pediatric Care and Support | $16,218,090 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,850,989 |
| HLAB: Laboratory Infrastructure | $14,262,090 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,572,171 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,938,895 |
| HMIN: Biomedical Prevention: Injection Safety | $275,000 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $245,000 |
| HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$1,129,916,124
View countries
Deloitte Consulting Limited:
$25,168,094
View countries